☰

OPPORTUNITY

THE LIBA3™ PLATFORM PROVIDES OPPORTUNITIES TO MANY HEALTHCARE PROVIDERS

1. Clinical Trial Cardiac Data Collection.

2. Licensing the Liba3™ platform to OEMs & Strategic Business Partners for integrating into and commercializing remote patient monitoring programs

Liba 3 helps cardiac patients enjoy a better life

MARKET DRIVERS

PATIENTS

Aging population, growing prevalence of cardiovascular disease in all age groups suffering from complex co-morbidities

PROVIDERS

Rising costs, shortage of talent, growing capacity and budget constraints

PAYERS

Increasing pressure to provide cost-effective, high-quality outcomes

CLINICAL TRIALS

Supporting decentralized clinical trials

PANDEMIC

Demand surges for telehealth technologies to monitor patients at home while minimizing exposure to coronavirus

ATRIAL FIBRILLATION

$26B ANNUALLY

IN U.S. HEALTH CARE COSTS ASSOCIATED WITH AFIB.

MARKET OPPORTUNITY

CLINICAL TRIAL CARDIAC RISK MONITORING

OFFICE AND CLINIC BASED CARDIAC DIAGNOSTICS

POST MARKETING FOR NEW THERAPIES